A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers
Phase of Trial: Phase II
Latest Information Update: 06 Oct 2017
At a glance
- Drugs VF 001 (Primary)
- Indications Varicose ulcer
- Focus Therapeutic Use
- Sponsors Factor Therapeutics
- 20 Dec 2016 According to Factor Therapeutics media release, the company has announced that it has enrolled the first patient and is targeting a top-line read-out of efficacy by Q4 2017.
- 20 Dec 2016 Status changed from not yet recruiting to recruiting, according to Factor Therapeutics media release.
- 29 Nov 2016 New trial record